Holen Sie sich die Stockscreener-App
7.74
2.89%
-0.23
Vorhandelsmarkt:
7.70
-0.04
-0.52%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt AVXL?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$7.97
Offen:
$7.9
24-Stunden-Volumen:
1.66M
Relative Volume:
1.48
Marktkapitalisierung:
$664.82M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-48.17M
KGV:
-13.58
EPS:
-0.57
Netto-Cashflow:
$-37.10M
1W Leistung:
-8.83%
1M Leistung:
-22.29%
6M Leistung:
-17.31%
1J Leistung:
+13.24%
1-Tages-Spanne:
$7.45
$7.938
1-Wochen-Bereich:
$7.45
$8.45
52-Wochen-Spanne:
$6.62
$14.44
Anavex Life Sciences Corporation Stock (AVXL) Company Profile
Firmenname
Anavex Life Sciences Corporation
Sektor
Branche
Telefon
844-689-3939
Adresse
630 5TH AVENUE, NEW YORK
Vergleichen Sie AVXL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVXL
Anavex Life Sciences Corporation
|
7.74 | 684.57M | 0 | -48.17M | -37.10M | -0.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Anavex Life Sciences Corporation Stock (AVXL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-12-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-23 | Eingeleitet | Berenberg | Buy |
| 2021-09-23 | Eingeleitet | BTIG Research | Buy |
| 2020-12-16 | Bestätigt | H.C. Wainwright | Buy |
| 2020-09-28 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2020-02-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-06-18 | Eingeleitet | Janney | Buy |
| 2018-05-16 | Fortgesetzt | Maxim Group | Buy |
| 2018-03-08 | Eingeleitet | ROTH Capital | Buy |
| 2018-02-13 | Bestätigt | Maxim Group | Buy |
| 2017-09-29 | Fortgesetzt | Noble Financial | Buy |
| 2017-02-07 | Eingeleitet | Noble Financial | Buy |
| 2016-03-29 | Eingeleitet | FBR Capital | Outperform |
Alle ansehen
Anavex Life Sciences Corporation Aktie (AVXL) Neueste Nachrichten
Will Anavex Life Sciences Corp. (12X1) stock rise with strong economyWeekly Stock Report & Daily Volume Surge Trade Alerts - newser.com
Real time breakdown of Anavex Life Sciences Corp. stock performanceQuarterly Portfolio Summary & Daily Oversold Stock Bounce Ideas - newser.com
Can Anavex Life Sciences Corp. stock deliver strong Q4 earningsQuarterly Trade Review & Short-Term High Return Strategies - newser.com
Will Anavex Life Sciences Corp. (12X1) stock top growth indexes2025 Top Gainers & Free Technical Pattern Based Buy Signals - newser.com
Can Anavex Life Sciences Corp. (12X1) stock deliver double digit returnsWeekly Profit Analysis & Free High Accuracy Swing Entry Alerts - newser.com
Anavex Life Sciences (NASDAQ:AVXL) Earns Buy Rating from D. Boral Capital - MarketBeat
Anavex Life Sciences (AVXL) Price Target Increased by 28.16% to 44.88 - Nasdaq
D. Boral Capital Maintains Anavex Life Sciences (AVXL) Buy Recommendation - Nasdaq
AVXL Stock Price and Chart — NASDAQ:AVXL - TradingView
Anavex Life Sciences announces continued long-term benefit from oral blarcamesine in Alzheimer's disease - MarketScreener
Anavex Life Sciences Announces Continued Long-Term Benefit from Oral Blarcamesine Compared to Decline Observed in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Control Group - markets.businessinsider.com
Anavex Life Sciences Reports Significant Cognitive Benefits of Blarcamesine in Alzheimer's Treatment Compared to Control Group - Quiver Quantitative
Why Is Anavex Life Sciences Stock Trading Higher Today?Anavex Life Sciences (NASDAQ:AVXL) - Benzinga
Anavex (NASDAQ: AVXL) announces 77.4 weeks 'time saved' with blarcamesine over 144 weeks - Stock Titan
Can Anavex Life Sciences Corp. stock rebound after recent weaknessJuly 2025 Big Picture & Weekly Consistent Profit Watchlists - fcp.pa.gov.br
Published on: 2025-10-28 04:23:07 - fcp.pa.gov.br
Is Anavex Life Sciences Corp. (12X1) stock testing key supportQuarterly Earnings Summary & High Yield Stock Recommendations - newser.com
Can Anavex Life Sciences Corp. stock sustain institutional interest2025 Volatility Report & Reliable Volume Spike Trade Alerts - fcp.pa.gov.br
Is Anavex Life Sciences Corp. stock vulnerable to regulatory risks2025 Market Overview & Safe Entry Momentum Tips - fcp.pa.gov.br
Is Anavex Life Sciences Corp. stock resilient to inflationMarket Activity Report & Weekly Chart Analysis and Guides - newser.com
Backtesting results for Anavex Life Sciences Corp. trading strategiesMarket Risk Analysis & Weekly Watchlist of Top Performers - newser.com
Is Anavex Life Sciences Corp. stock undervalued vs historical averages2025 Price Action Summary & Free Long-Term Investment Growth Plans - newser.com
Anavex Life Sciences Corp. $AVXL Shares Acquired by 180 Wealth Advisors LLC - MarketBeat
Why millennials buy Anavex Life Sciences Corp. (12X1) stockShort Setup & AI Enhanced Trade Execution Alerts - newser.com
Candlestick signals on Anavex Life Sciences Corp. stock todayPortfolio Return Summary & Reliable Volume Spike Alerts - newser.com
Anavex Life Sciences' (AVXL) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
What analysts say about Anavex Life Sciences Corp stockMarket Correction Analysis & Free Significant Capital Appreciation - earlytimes.in
Anavex Life Sciences (NASDAQ:AVXL) Trading Down 4.9%Should You Sell? - MarketBeat
Jones Trading Downgrades Anavex Life Sciences (NASDAQ:AVXL) to Hold - MarketBeat
Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring a Promising 403% Upside in the Biotechnology Sector - DirectorsTalk Interviews
Anavex Life Sciences (NASDAQ:AVXL) Shares Pass Above 50 Day Moving AverageTime to Sell? - MarketBeat
Jones Trading downgrades Anavex stock to Hold ahead of critical EMA decision - Investing.com UK
How strong is Anavex Life Sciences Corp. stock revenue growthJuly 2025 Catalysts & Reliable Momentum Entry Alerts - newser.com
Visual trend scoring systems applied to Anavex Life Sciences Corp.July 2025 WrapUp & AI Enhanced Trading Alerts - newser.com
Tools to monitor Anavex Life Sciences Corp. recovery probabilityPortfolio Update Summary & Daily Stock Trend Watchlist - newser.com
Visualizing Anavex Life Sciences Corp. stock with heatmapsJuly 2025 Levels & High Accuracy Buy Signal Tips - newser.com
Heatmap analysis for Anavex Life Sciences Corp. and competitors2025 Stock Rankings & Expert Curated Trade Ideas - newser.com
How Anavex Life Sciences Corp. stock reacts to global recession fearsQuarterly Profit Summary & Safe Swing Trade Setups - Trung tâm Dự báo KTTV quốc gia
Anavex Life Sciences (STU:12X1) Cyclically Adjusted PS Rati - GuruFocus
Will Anavex Life Sciences Corp. (12X1) stock keep high P E multiplesMarket Performance Summary & Precise Buy Zone Identification - nchmf.gov.vn
Can trapped investors hope for a rebound in Anavex Life Sciences Corp.July 2025 PostEarnings & Daily Price Action Insights - newser.com
Aug Weekly: Can Anavex Life Sciences Corp. stock weather global recessionQuarterly Portfolio Report & Fast Gain Stock Tips - Trung tâm Dự báo KTTV quốc gia
Geopolitics Watch: How Anavex Life Sciences Corp. stock valuations compare to rivalsJuly 2025 Retail & Low Drawdown Momentum Ideas - Trung tâm Dự báo KTTV quốc gia
Will Anavex Life Sciences Corp. stock split again soonInflation Watch & Proven Capital Preservation Tips - Trung tâm Dự báo KTTV quốc gia
How Anavex Life Sciences Corp. stock valuations compare to rivalsTreasury Yields & Verified Swing Trading Watchlists - Trung tâm Dự báo KTTV quốc gia
Can machine learning forecast Anavex Life Sciences Corp. recoveryRate Cut & Consistent Return Strategy Ideas - newser.com
Anavex Life Sciences Corp. (AVXL) Stock Analysis: A 281% Potential Upside On The Horizon - DirectorsTalk Interviews
US High Growth Tech Stocks To Watch For Potential Expansion - simplywall.st
Finanzdaten der Anavex Life Sciences Corporation-Aktie (AVXL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):